Nitazoxanide: all 99 studies that test it

Page 1 of 1. Open to participants first (13), then studies with results posted, then the rest; newest registration first within each.

• Nitazoxanide as Adjunct Therapy in Mild-to-Moderate Ulcerative ColitisNot yet recruitingNCT07820046Phase 2/3
• Nitazoxanide in Spontaneous Bacterial PeritonitisNot yet recruitingNCT07808450Phase 1/2
• A Clinical Trial Evaluating Fecal Microbiota Transplantation (FMT) in Adolescents With ADHDNot yet recruitingNCT07756255Phase 2
• Nitazoxanide in Patients With Ulcerative ColitisRecruitingNCT06993974Phase 2
• Nitazoxanide for Treatment of Cryptosporidium in ChildrenNot yet recruitingNCT06600711Phase 3
• Nitazoxanide in Patients With Metastatic Colorectal CancerRecruitingNCT06049901Phase 3
• Nitazoxanide as Adjuvant Therapy in Type 2 Diabetes MellitusRecruitingNCT06010992Phase 2
• Combination Therapy Between Doxycycline, Pentoxifylline, and Nitazoxanide in Sexually Active MenNot yet recruitingNCT05897034Phase 2/3
• Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)RecruitingNCT05041907Phase 2
• AGILE (Early Phase Platform Trial for COVID-19)RecruitingNCT04746183Phase 1/2
• Study of Nitazoxanide (NTZ) for Helicobacter Pylori in ChildrenRecruitingNCT04415983Phase 3
• Novel Regimens in COVID-19 TreatmentRecruitingNCT04382846Phase 3
• Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic EncephalopathyRecruitingNCT04161053Phase 3
• A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19TerminatedNCT04605588Phase 2Results posted
• Four Different Experimental Drug Regimens to Standard of Care for the Treatment of Symptomatic Outpatients With COVID-19CompletedNCT04532931Phase 2Results posted
• Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus InfectionTerminatedNCT04489381Phase 3Results posted
• Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19CompletedNCT04486313Phase 3Results posted
• Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 InfectionCompletedNCT04359680Phase 3Results posted
• Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF)TerminatedNCT04343248Phase 3Results posted
• Study of Nitazoxanide Compared to Placebo in Subjects With HBeAG-Negative Chronic Hepatitis BCompletedNCT03905655Phase 2Results posted
• An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With FibrosisCompletedNCT03656068Phase 2Results posted
• Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus InfectionCompletedNCT03605862Phase 3Results posted
• NNITS-Nitazoxanide for Norovirus in Transplant Patients StudyCompletedNCT03395405Phase 2Results posted
• A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Uncomplicated InfluenzaCompletedNCT03336619Phase 3Results posted
• Nitazoxanide Versus Placebo for the Treatment of Hospitalized Subjects With Severe Acute Respiratory IllnessCompletedNCT02057757Phase 2Results posted
• The Role Of Nitazoxanide, Interferon Alfa And Ribavirin In Treatment Of Hepatitis C Infected Type 2 Diabetic PatientsCompletedNCT01770483Phase 4Results posted
• Efficacy of Nitazoxanide in the Treatment of Chronic Hepatitis C Virus (HCV)CompletedNCT01276756Phase 2/3Results posted
• Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated InfluenzaCompletedNCT01227421Phase 2/3Results posted
• A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment FailuresCompletedNCT01185028Phase 1/2Results posted
• Study of Nitazoxanide in Adults With Acute Uncomplicated InfluenzaTerminatedNCT01056380Phase 2Results posted
• Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected SubjectsCompletedNCT00991289Phase 2Results posted
• Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C PatientsCompletedNCT00637923Phase 2Results posted
• Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis CCompletedNCT00495391Phase 2Results posted
• Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile InfectionCompletedNCT00304356Phase 3Results posted
• Nitazoxanide vs Metronidazole for Entamoeba Diarrhea in ChildrenCompletedNCT07790926Phase 2
• Efficacy of Nitazoxanide Based Therapy vs Standard Triple Therapy in H-pylori in ChildrenCompletedNCT07086937Not applicable
• Comparative Study of Secondary Prophylaxis for SBPCompletedNCT06827756Phase 4
• Pharmacokinetic Interaction Between Nitazoxanide and Atazanavir/Ritonavir in Healthy VolunteersCompletedNCT05680792Not applicable
• Effect of the Nutritional Support System on Neuromotor Alterations in Patients With Cerebral PalsyStatus unknownNCT05648422Not applicable
• Role of Nitazoxanide and Escitalopram in Patients With Rheumatoid ArthritisCompletedNCT05480878Phase 3
• Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without ConstipationWithdrawnNCT05453916Phase 1/2
• Nitazoxanide Pharmacokinetic Parameters in Renal Impaired SubjectsCompletedNCT05368935Phase 1
• Trial to Evaluate Nitazoxanide for Treatment of Mild COVID-19 in Subjects Not at High Risk of Severe IllnessWithdrawnNCT05157269Phase 3
• Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe IllnessWithdrawnNCT05157243Phase 3
• Nitazoxanide Pharmacokinetic Parameters in Hepatic Impaired PatientsCompletedNCT05116826Phase 1
• MANS-NRIZ Trial for COVID-19 Treatment : Extension StudyStatus unknownNCT04959786Phase 2/3
• Favipiravir +/- Nitazoxanide: Early Antivirals Combination Therapy in COVID-19CompletedNCT04918927Phase 2
• Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19 in Household ContactsStatus unknownNCT04788407Phase 4
• Nitazoxanide in Prevention of Secondary Spontaneous PeritonitisStatus unknownNCT04746937Phase 3
• Nitazoxanide Therapy for Patients With COVID-19 PneumoniaCompletedNCT04561219Phase 2
• COVID-19 Prophylaxis South Africa (COVER HCW)CompletedNCT04561063Phase 2
• Effects of Early Use of Nitazoxanide in Patients With COVID-19CompletedNCT04552483Phase 2
• Catalysing the Containment of COVID-19TerminatedNCT04523090Phase 2/3
• Sofosbuvir/Ledipasvir and Nitazoxanide for Treatment of COVID-19CompletedNCT04498936Phase 4
• Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19)Status unknownNCT04463264Phase 2/3
• The Nitazoxanide Plus Atazanavir for COVID-19 StudyTerminatedNCT04459286Phase 2
• Efficacy and Safety of Nitazoxanide 600 mg to Treat Mild Ambulatory COVID-19 PatientsWithdrawnNCT04441398Phase 2/3
• Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19WithdrawnNCT04435314Phase 2
• Efficacy and Safety of Nitazoxanide 600 mg BID Versus Placebo for the Treatment of Hospitalized Patients With COVID-19Status unknownNCT04423861Phase 3
• Prevention of Coronavirus Disease (COVID-19) Outbreaks With NitazoxanideCompletedNCT04406246Phase 4
• Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19Status unknownNCT04361318Phase 2/3
• Ivermectin and Nitazoxanide Combination Therapy for COVID-19Status unknownNCT04360356Phase 2/3
• Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19CompletedNCT04348409Not applicable
• Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19TerminatedNCT04341493Phase 4
• Role of Intestinal Protozoa and Helminths in the Course of Ulcerative ColitisActive, not recruitingNCT03441893Phase 1/2
• Early Life Interventions for Childhood Growth and Development In TanzaniaCompletedNCT03268902Phase 2/3
• A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of TuberculosisCompletedNCT02684240Phase 2
• A Two Week Nitazoxanidebased Quadruple RegimenStatus unknownNCT02621359Phase 3
• Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated InfluenzaCompletedNCT02612922Phase 3
• Nitazoxanide Plus Lactulose Versus Lactulose Alone Treatment of Hepatic EncephalopathyStatus unknownNCT02464124Phase 2/3
• Finding Better Treatment of Bronchiolitis: A Clinical Trial of Oral Nitazoxanide for the Treatment of Bronchiolitis in Infants Presenting to Hospital Emergency DepartmentsWithdrawnNCT02452905Phase 2
• Study of Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter PyloriStatus unknownNCT02422706Phase 3
• The Effects of Nitazoxanide in Hepatic EncephalopathyStatus unknownNCT02334163Phase 2
• Oral Nitazoxanide in Acute Gastroenteritis in Australian Indigenous ChildrenTerminatedNCT02165813Phase 2/3
• Trial Comparing the Efficacy, Tolerability and Safety Between Three Arms in Treatment of HCV in Egyptian PopulationStatus unknownNCT01896609Phase 4
• Irritable Bowel Syndrome Evaluation and Treatment in Primary CareCompletedNCT01641341Phase 4
• Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated InfluenzaCompletedNCT01610245Phase 3
• Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV CoinfectionStatus unknownNCT01529073Phase 2
• Efficacy Study of Nitazoxanide Suspension in the Treatment of Rotavirus Disease in ChildrenCompletedNCT01328925Phase 2
• Nitazoxanide for the Treatment of Prolonged Diarrhea in ChildrenCompletedNCT01326338Phase 3
• Study of the Impact of Nitazoxanide on Chronic Hepatitis PatientsCompletedNCT01197157Phase 2/3
• Hyperproteic Diet Plus Lactobacillus Reuteri and Nitazoxanide in Minimal Hepatic EncephalopathyCompletedNCT01135628Not applicable
• A Pilot Study to Examine the Role of Nitazoxanide to Prevent Recurrence of Hepatitis C After TransplantationCompletedNCT01074203Phase 1
• 4-Week Lead-In With Nitazoxanide Followed by 36 Weeks Nitazoxanide and Peginterferon Alfa-2a in Chronic Hepatitis CCompletedNCT00763568Phase 2
• Use of Nitazoxanide and Probiotics in Acute Diarrhea Secondary to RotavirusCompletedNCT00683982Not applicable
• Study of Nitazoxanide, Peginterferon, and Ribavirin Combination Therapies in the Treatment of Chronic Hepatitis CCompletedNCT00421434Phase 2/3
• Study of Nitazoxanide in the Treatment of Chronic Hepatitis CCompletedNCT00418639Phase 2
• Study of Nitazoxanide Combined With Peginterferon Compared to Peginterferon Monotherapy in the Treatment of Hepatitis CCompletedNCT00418054Phase 2
• Study of Nitazoxanide in the Treatment of Clostridium Difficile ColitisCompletedNCT00417872Phase 2
• Study of Nitazoxanide in the Treatment of Clostridium Difficile-associated DiseaseTerminatedNCT00384527Phase 3
• Study of Nitazoxanide in the Treatment of Amebiasis in ChildrenCompletedNCT00366730Phase 3
• Study of Nitazoxanide in the Treatment of Amebiasis in Adults and AdolescentsCompletedNCT00366236Phase 3
• Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in ChildrenCompletedNCT00302640Phase 2/3
• Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's DiseaseTerminatedNCT00130390Phase 2
• Nitazoxanide for the Treatment of Chronic Diarrhea in HIV Infected ChildrenCompletedNCT00055107Phase 1/2
• Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS PatientsTerminatedNCT00004986Phase 3
• A Study of Nitazoxanide in the Treatment of AIDS-Related DiarrheaCompletedNCT00002444Phase 1
• A Study to Evaluate the Use of Nitazoxanide to Treat CryptosporidiosisStatus unknownNCT00002158Not applicable
• A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by CryptosporidiumCompletedNCT00001081Phase 2

← Nitazoxanide overview